Similar articles

• Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.

  Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G, Szili-Török T, Linde C; REVERSE Study Group. Daubert C, et al. J Am Coll Cardiol. 2009 Nov 10;54(20):1837-46. doi: 10.1016/j.jacc.2009.08.011. Epub 2009 Oct 1. J Am Coll Cardiol. 2009. PMID: 19800193 Clinical Trial.
• Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.

  Chapa DW, Lee HJ, Kao CW, Friedmann E, Thomas SA, Anderson J, Bardy GH. Chapa DW, et al. Am J Crit Care. 2008 Sep;17(5):443-52; quiz 453. Am J Crit Care. 2008. PMID: 18776000 Review.
• Left ventricular endocardial pacing improves the clinical efficacy in a non-responder to cardiac resynchronization therapy: role of acute haemodynamic testing.

  Bracke FA, Houthuizen P, Rahel BM, van Gelder BM. Bracke FA, et al. Europace. 2010 Jul;12(7):1032-4. doi: 10.1093/europace/euq043. Epub 2010 Mar 2. Europace. 2010. PMID: 20200018 No abstract available.
• Resynchronization therapy for the treatment of heart failure.

  Saxon LA, Ellenbogen KA. Saxon LA, et al. Circulation. 2003 Sep 2;108(9):1044-8. doi: 10.1161/01.CIR.0000085656.57918.B1. Circulation. 2003. PMID: 12952826 Review. No abstract available.
• Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.

  Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C. Ghanbari H, et al. Arch Intern Med. 2009 Sep 14;169(16):1500-6. doi: 10.1001/archinternmed.2009.255. Arch Intern Med. 2009. PMID: 19752408